Skip to content
Search

Latest Stories

PNB Fraud: RBI officials under CBI's scanner

India's investigating agency Central Bureau of Investigation has questioned four officers belonging to the Reserve Bank of India in connection with the Rs 13,000 crore Punjab National Bank (PNB) fraud.

The officials belong to the foreign exchange department of the central bank, The Indian Express reported, adding that they were also questioned on the fraud Letters of Undertaking (LoUs) issued to diamond billionaire Nirav Modi’s firms.


The scam came to light on February 14 and the government has appointed the CBI and ED on the case, which is still ongoing. A few PNB officials posted at the Brady House branch of the bank have been accused of generating fake letters of credit that helped Modi's firms loan money from a few foreign branches of the Indian banks. Efforts have been made to bring Modi back to India, but he has not shown any inclination to co-operate with India's investigating agencies.

Meanwhile, PNB's MD and CEO Sunil Mehta recently told Business Standard that the bank was confident of recovering from the losses of Rs 130 billion scam related to Modi and his uncle Mehul Choksi. The bank was also set to file a recovery suit to seal assets of the firms involved in the fraud.

On being asked if PNB feels like it has been made a scapegoat in this incident when other banks were also involved in the transactions with Modi and Choksi, Mehta said they have "lived by the reputation of PNB."

"We have said the letters of undertaking (LoUs) were issued by the employees of PNB. We said even if they were issued fraudulently, PNB will honour its commitment because it’s the matter of reputation of the bank. Also, I will not comment on it as it is a subject matter of investigation. Meantime, to ensure other banks don’t suffer, we have taken adequate precautions and a historic step to honour all the commitments," Mehta told Business Standard.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less